As 1 of 4 patent holders Voit has a vested interest in micro-dystrophin (thus Sarepta) succeeding, but that doesn't mean there's a conflict of interest.
There would be a conflicting interest if he were PI for us and we were competing with Sarepta, but wouldn't a partnership remove conflict from the equation?
i.e. The Voit PI theory bolsters the Sarepta partnership theory and vice versa.
At this juncture, it's probably worth recalling that Voit was talking up combination therapy (and our results) before Sarepta failed. I wonder what advice he's giving now...
Good luck guys!!
p.s. I actually responded to the wrong post, sorry Uboy. I clearly need some sleep.
- Forums
- ASX - By Stock
- PER
- Where others have failed will Atl1102 succeed ?
Where others have failed will Atl1102 succeed ?, page-905
-
-
- There are more pages in this discussion • 192 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $75.73M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 6056 | 8.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.7¢ | 119843 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 6056 | 0.085 |
2 | 262571 | 0.084 |
1 | 10000 | 0.083 |
2 | 193598 | 0.082 |
2 | 49037 | 0.081 |
Price($) | Vol. | No. |
---|---|---|
0.087 | 119843 | 1 |
0.088 | 13868 | 1 |
0.089 | 14285 | 1 |
0.090 | 546175 | 2 |
0.091 | 108000 | 1 |
Last trade - 09.41am 20/06/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
Day chart unavailable
The Watchlist
CC9
CHARIOT CORPORATION LTD
Shanthar Pathmanathan, MD
Shanthar Pathmanathan
MD
Previous Video
Next Video
SPONSORED BY The Market Online